Viewing Study NCT06943950


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2025-12-27 @ 12:50 PM
Study NCT ID: NCT06943950
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-30
First Post: 2025-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module